NCT01489995 - Migalastat Food Effect Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Fabry Disease

Interventions

DRUG

A (migalastat)

150 mg migalastat HCl in the fasting state (reference arm)

DRUG

B (migalastat)

150 mg migalastat HCl with simultaneous consumption of a glucose drink

DRUG

C (migalastat)

150 mg migalastat HCl 1 hour before consumption of a high fat meal

DRUG

D (migalastat)

150 mg migalastat HCl 1 hour before consumption of a light meal

DRUG

E (migalastat)

150 mg migalastat HCl 1 hour after consumption of a light meal

Trial Locations (1)

GSK Investigational Site, Austin